APA (7th ed.) Citation

Natalie J. Hannan, Paul A. Cohen, Sally Beard, Sanela Bilic, Bonnie Zhang, Stephen Tong, . . . Lisa Hui. (2022). Transcriptomic analysis of patient plasma reveals circulating miR200c as a potential biomarker for high-grade serous ovarian cancer. Elsevier.

Chicago Style (17th ed.) Citation

Natalie J. Hannan, Paul A. Cohen, Sally Beard, Sanela Bilic, Bonnie Zhang, Stephen Tong, Clare Whitehead, and Lisa Hui. Transcriptomic Analysis of Patient Plasma Reveals Circulating MiR200c as a Potential Biomarker for High-grade Serous Ovarian Cancer. Elsevier, 2022.

MLA (9th ed.) Citation

Natalie J. Hannan, et al. Transcriptomic Analysis of Patient Plasma Reveals Circulating MiR200c as a Potential Biomarker for High-grade Serous Ovarian Cancer. Elsevier, 2022.